| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Women |
| Source | The Week |
| URL | theweek.com/health/the-growing-use-of-testosterone-to-treat-menopause (opens in a new tab) |
Specific Claim Evaluated
A UK clinic study of 510 women reported improvements in mood, cognitive symptoms and libido after 4 months of testosterone, but the findings do not prove causation, and placebo-controlled trials have not shown benefits for brain fog, mood, bone density or fatigue.
Primary Research Supporting or Contradicting the Claim
The 510-woman study was a retrospective cohort in a UK specialist menopause clinic without a control group (Glynne et al., 2024). A 2026 meta-analysis found evidence insufficient to establish an effect of testosterone on cognition in menopause (Faulkner et al., 2026), and the consensus statement limits the evidence-based indication to hypoactive sexual desire disorder (Davis et al., 2019).
Corrected Evidence-Based Interpretation
The report is correct.
Rationale for Grade
The article presents the uncontrolled study alongside expert caution and the absence of randomized evidence for nonsexual outcomes, and notes uncertain long-term safety. Its claims are consistent with the primary research.
References
- Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD." - Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect" - Glynne S, Kamal A, Kamel AM, Reisel D, Newson L. Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study. Arch Womens Ment Health. 2025;28(3):541-550 (published online 2024). PMID
Supporting excerpt: "A retrospective cohort study undertaken in a UK specialist menopause clinic."